自主造血干细胞移植用于治疗多发性硬化症
Lindsay A Ross1, Lisa M Stropp1, Jeffrey A Cohen1
1Mellen Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Neurologic clinics
|November 18, 2023
概括
自主造血干细胞移植 (AHSCT) 对复发性多发性硬化症 (MS) 显示出强大而持久的有效性. 虽然昂贵且带有风险,但对于那些对其他疗法没有反应的活跃多发性硬化病例来说,它是可行的治疗方法.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 复发性多发性硬化症 (MS) 是一种慢性自身免疫性疾病,影响中枢神经系统.
- 目前用于MS的疾病修饰疗法 (DMT) 有不同的疗效和安全性.
- 为患有活跃多发性硬化和对标准治疗反应不足的患者寻求高效疗法.
研究的目的:
- 评估自身造血干细胞移植 (AHSCT) 对复发性多发性硬化症 (MS) 的疗效和安全性.
- 与其他高效疗法相比,将AHSCT置于复发性MS的治疗算法中.
主要方法:
- 对复发性MS的AHSCT现有数据的审查和汇总.
- 分析与AHSCT相关的安全概况和财务成本.
- 考虑正在进行的随机对照试验,将AHSCT与其他高效性MS疗法进行比较.
主要成果:
- 现有数据表明,AHSCT在治疗复发性多发性硬化症方面表现出强大而持久的疗效.
- 显著的安全问题和财务成本主要与移植程序本身有关.
- 对于那些对现有疗法没有充分反应的高活性复发性MS患者来说,AHSCT被认为是合理的治疗选择.
结论:
- 自主造血干细胞移植是复发性多发性硬化症的有效治疗方法.
- 对于MS患者的一个特定子集来说,AHSCT代表了一种有价值的治疗选择.
- 通过正在进行的随机试验进行进一步的研究至关重要,以最终确定AHSCT与其他先进的MS治疗的相对益处和风险概况.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Bone Marrow Sampling and Transplants
334
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
334
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K


